MAPK Pathway Suppression Unmasks Latent DNA Repair Defects and Confers a Chemical Synthetic Vulnerability in <i>BRAF-, NRAS</i> -, and <i>NF1</i> -Mutant MelanomasOphélia Maertens, Karen Cichowski, Ryan Kuzmickas et al.|Cancer Discovery|2019Cited by 106
A Deregulated HOX Gene Axis Confers an Epigenetic Vulnerability in KRAS-Mutant Lung CancersStephanie Guerra, Karen Cichowski, Amanda J. Redig et al.|Cancer Cell|2020Cited by 56
Abstract LB-113: MAPK pathway suppression unmasks latent DNA repair defects and confers a chemical synthetic vulnerability in <i>BRAF</i> , <i>NRAS</i> and <i>NF1-</i> mutant melanomasOphélia Maertens, Karen Cichowski, Ryan Kuzmickas et al.|Cancer Research|2019Cited by 0
Supplementary Data from MAPK Pathway Suppression Unmasks Latent DNA Repair Defects and Confers a Chemical Synthetic Vulnerability in <i>BRAF-, NRAS</i>-, and <i>NF1</i>-Mutant MelanomasOphélia Maertens, Karen Cichowski, Ryan Kuzmickas et al.|Unknown|2023Cited by 0
Supplementary Figures 1-5 from MAPK Pathway Suppression Unmasks Latent DNA Repair Defects and Confers a Chemical Synthetic Vulnerability in <i>BRAF-, NRAS</i>-, and <i>NF1</i>-Mutant MelanomasOphélia Maertens, Karen Cichowski, Ryan Kuzmickas et al.|Unknown|2023Cited by 0